Cycle on Jun 22, 2026

I will start by listing the open threads and watches for this topic to see what specific questions or triggers we are tracking.

I will list the existing notes to see what prior findings we have on file for this topic.

Let's check the current date. It is June 22, 2026. There is a watch for: 1. "Centene June 2026 Wakely Risk Adjustment Data Release" with fire date June 30, 2026. 2. "CMS Star Ratings October 2026 Announcement" (fire date October 15, 2026). 3. "Federal Court Ruling on Optum Rx California S.B. 41 Lawsuit" (fire date December 31, 2026). 4. "Congress Progress on Patients Before Monopolies Act (PBM Act)" (ongoing). Let's search for the latest updates on Centene and the Wakely Consulting risk adjustment data (since it's late June 2026, there might be early releases or discussions about it), or look for any recent news on health insurers, PBM regulatory crackdowns, or FTC/DOJ actions. We should also run `market_view` for the major tickers: UNH, ELV, CI, CVS, HUM, CNC. Let's first call `market_view` for UNH, ELV, CI, CVS, HUM, CNC to see if there are latest earnings or price movements. I'll call them one by one or in batches. Let's start with UNH.

Let's pull market views for the other major health insurers as well: ELV, CI, CVS, HUM, CNC. Let's call `market_view` for HUM.

Let's check the rest of the companies: ELV, CI, CVS, CNC. I will call `market_view` for ELV and CI first.

Let's pull CI.

Let's pull CVS and CNC.

Now let's pull CNC.

Interesting, we have quite a few recent things. Let's see what else has happened. Let's do a web search for the Wakely risk adjustment data for Centene, and any recent Medicare Advantage Star ratings news or Humana updates (e.g. the "Medicare Advantage star ratings redo boosts Humana, Clover Health" from mid-June 2026). Let's search for "Wakely risk adjustment Centene June 2026" or "Wakely Consulting Group risk adjustment 2026" using `web_search`.

Ah! The Wakely National Risk Adjustment Reporting (WNRAR) project and Centene. Let's see: "Marketplace Risk Adjustment Upside: If June Wakely confirms full receivable, management estimates a range wrapping around the original 4% target..." from `healthworksai.com` - let's fetch that URL to read what Centene said on their Q1 2026 earnings call about the Wakely risk adjustment and the June catalyst. Let's first fetch `https://healthworksai.com/insights/centene-corporation-q1-2026-earnings-call-insight/`.

The Q1 2026 earnings call insight for Centene provides fantastic, detailed context. Let's see what else has happened on the Wakely risk adjustment data. Is there a recent report in June 2026? Let's do a web search for "Wakely June 2026 risk adjustment" or "Wakely National Risk Adjustment Reporting 2026". Or look at the CMS risk adjustment release. The CMS risk adjustment report for the 2025 benefit year is typically released in late June or early July (historically around June 30 or early July). Let's search for "CMS risk adjustment report 2026" or "CMS risk adjustment 2025 benefit year" to see if it has been released or if there are preliminary Wakely reports.

Ah, let's search for "CMS risk adjustment report 2025 benefit year release date" or look up when the CMS 2025 benefit year risk adjustment report comes out in 2026. Wait, let's do a search for "CMS risk adjustment report June 2026" or "CMS risk adjustment June 2026". Let's use `web_search`.

Let's fetch the first URL `https://www.cms.gov/marketplace/health-plans-issuers/premium-stabilization-programs` to see if there is any 2025 benefit year risk adjustment report posted in June 2026. Wait, let's also do a search on "Centene Wakely June 2026" or "Centene risk adjustment June 2026". Let's use `web_search`.

Let's look at that Medium post title: "Centene's Meltdown: The Day the Facade Cracked" and the PDF of the Form 10-Q for Centene Corp filed 04/28/2026. Wait, let's look up the Medium post "Centene's Meltdown: The Day the Facade Cracked" or search for "Centene risk adjustment 2025" or "Centene 2025 guidance withdraw". Ah! In July 2025 (or around then), did Centene withdraw its 2025 guidance due to risk-adjustment concerns? Let's check: "CENTENE CORPORATION WITHDRAWS 2025 GUIDANCE" was on July 1, 2025. And "Centene pulls guidance amid ACA risk-adjustment concern" from Modern Healthcare. Wait, let's fetch the Centene 10-Q filed 04/28/2026 or search about Centene's risk adjustment details. Let's first search for "Centene Meltdown Day the Facade Cracked" to understand what that is. Is it about their risk adjustment issues in 2025? Let's search using `web_search`.

Let's fetch `https://medium.com/@centengate3/centenes-meltdown-the-day-the-facade-cracked-68cfbe249843` to read about what happened. This seems to describe the risk adjustment dynamics in detail.

This Medium article provides historical context. In June 2025 (which was last year, given that it is now June 2026), Centene experienced a massive drop and pulled its 2025 guidance due to a $1.8 billion shortfall in risk adjustment payments. Now, in June 2026, Centene has returned to profitability (reporting a massive beat in Q1 2026 with EPS of $3.37 vs. $2.13 estimate). And they are waiting for the "June Wakely risk adjustment data" to confirm whether their higher-acuity silver-tier membership will yield a meaningful risk adjustment receivable, allowing them to hit or exceed their 4% Marketplace margin target for 2026. Let's see if there are any updates on the actual Wakely risk adjustment data for June 2026. Let's do a search on "Wakely June 2026" or "Wakely risk adjustment report June 2026" or "HHS risk adjustment report 2025 benefit year". Wait, let's search for "Wakely National Risk Adjustment Reporting 2026" or "WNRAR June 2026" or "Wakely ACA risk adjustment June 2026". Let's use `web_search`.

Let's fetch `https://www.wakely.com/blog/who-paid-and-who-stayed-early-2026enrollment-trends-in-the-individual-market/` to see if it has details on early 2026 enrollment trends and risk adjustment. This could be highly relevant for Centene's Marketplace risk adjustment. Let's fetch it.

Ah, that failed with a timeout. Let's try searching for the title of that PR Newswire release: "New Wakely white paper explores potential impacts of House reconciliation bill on ACA individual market coverage". Wait, let's search for "Who Paid, and Who Stayed? Early 2026 Enrollment Trends" to find a summary or another source. Or let's search for "Wakely Analysis Signals Significant Enrollment Shifts in ACA" or "Wakely 2026 individual market" to see what's happening. Let's use `web_search`.

Let's fetch `https://www.healthmanagement.com/blog/in-focus/early-signals-from-a-pivotal-aca-enrollment-year/` since healthmanagement.com is a highly trusted health policy consulting site and this will give us a complete breakdown of the "Who Paid, and Who Stayed? Early 2026 Enrollment Trends in the Individual Market" paper by Wakely. This is extremely important because Centene's Marketplace enrollment fell 36.4% YoY in Q1 2026 (down to 3.58M from 5.63M in Q1 2025) because of the expiration of the enhanced premium tax credits (eAPTC). Let's fetch it.

Let's analyze this! This is incredibly rich and directly addresses the core of our thesis and the specific Centene June 2026 risk adjustment catalyst. Let's synthesize what this means: - In Q1 2026, Centene's Marketplace (ACA) membership fell 36.4% YoY (to 3.58M from 5.63M in Q1 2025) because the enhanced premium tax credits (eAPTC) expired. - Nationwide, according to the Wakely report "Who Paid, and Who Stayed? Early 2026 Enrollment Trends in the Individual Market" (published April 15, 2026), only 86% of enrollees paid their January 2026 premium. The overall average enrollment decrease is estimated to be between 17% and 26% lower than 2025, and **morbidity is projected to worsen by 2.9% to 6.5%**. - Crucially, there was a massive shift in plan choice due to affordability pressures: Silver plan enrollment fell ~17% while Bronze enrollment increased by >10%. - For Centene, this is the exact driver of their expected **risk adjustment receivable**. Sicker, higher-acuity members stayed in the Silver plans (the "acuity-shifted silver-tier membership"), while healthier members migrated to Bronze plans or dropped out. - Centene's management has conservatively booked a 3% pre-tax Marketplace margin in guidance (vs. their original 4% target), but they explicitly stated that if the June Wakely data confirms the full risk adjustment receivable for this higher-acuity silver membership, it would wrap around or exceed their original 4% target. - Since the final risk adjustment transfers for the 2025 benefit year are determined in June 2026 (typically released by CMS on or around June 30, 2026), the Wakely data is the key near-term catalyst. Let's do some more web research to see if there is any other recent news on CMS rate notices, Medicare Advantage Star ratings, or PBM regulatory crackdowns. Let's search for "Medicare Advantage star ratings redo Humana 2026" or "CMS star ratings redo Clover Clover Health Humana" since we saw a headline in our market views: "Medicare Advantage star ratings redo boosts Humana, Clover Health" from June 19, 2026. Let's search for "Medicare Advantage star ratings redo Humana Clover Health June 2026" to find the details of this CMS Star ratings redo! This is a massive development for Humana, which was suffering from margin compression due to Star ratings drops and Medicare Advantage benefit cuts. Let's use `web_search`.

Let's fetch `http://www.modernhealthcare.com/insurance/mh-medicare-advantage-star-ratings-humana-clover/` (or search for a readable version or use `web_fetch` on `https://www.healthcaredive.com/news/cms-recalculates-medicare-advantage-stars-clover-lawsuit/823253/` since Healthcare Dive is open and has high-quality summaries). Let's fetch the Healthcare Dive URL first.

This is an exceptional development! Let's examine the details: 1. CMS is voluntarily recalculating the 2026 Star Ratings (which determine the 2027 Quality Bonus Payments) following Clover Health's court victory in Georgia in late May 2026. 2. In late May, a Georgia federal judge agreed with Clover and ordered CMS to recalculate Clover's largest contract (H8010) without 20 disputed measures. On June 9, 2026, CMS recalculated Clover's rating and raised it from 4.0 to 4.5 Stars (or 3.5 to 4.5, depending on the contract). 3. In response, CMS issued a memo on June 17, 2026, stating that it is voluntarily recalculating the 2027 Quality Bonus Payment ratings (based on the 2026 Star Ratings) for certain contracts, but *only* by removing measures where CMS conceded on the "data source" argument (i.e., data they didn't have explicit authority under the law to collect, such as foreign language interpreter availability, complaints against the health plan, and members choosing to leave the plan). 4. However, CMS did *not* remove the measures that Clover argued were included without proper rulemaking (which CMS wants to keep fighting on). 5. As a result, the voluntary recalculation has almost *no* impact on average star ratings for other insurers (besides Clover), which is a disappointment for giants like UnitedHealthcare (which would have seen a bump from 4.11 to 4.27 average stars, a $500 million benefit, if the full Clover criteria had been applied) and Elevance (which would have seen a $25 million benefit). 6. This sets up a major legal battlefront: other insurers might now sue CMS to force them to apply the full Clover ruling criteria, or wait for the October 2026 announcement of the 2027 Star Ratings (which determine the 2028 payments). Let's do some research on Humana's part. We saw the article: "Medicare Advantage star ratings redo boosts Humana, Clover Health". Let's see if there is any other specific impact on Humana. Let's do a web search for "Humana CMS star ratings recalculation June 2026". Let's use `web_search`.

Let's fetch `http://www.modernhealthcare.com/insurance/mh-cms-2026-medicare-advantage-star-ratings/` or search specifically about the Humana impact of this recalculation. Wait, let's search for "Humana 2026 star ratings recalculation" to find if they got any upgrade or if they are still suing. Let's do a search on "Humana star ratings lawsuit 2026" or "Humana files new lawsuit over Star rating" (as seen in the RISE Health headline). Let's use `web_search` to find out about Humana's legal status and star ratings.

Let's fetch `http://www.modernhealthcare.com/insurance/mh-medicare-advantage-star-ratings-humana-clover/` to see the details of how the recalculation affects Humana. This is very important. Let's fetch it. Wait, the previous fetch to modernhealthcare.com returned an error on another URL, let's see if we can fetch this one or if it fails. Let's try.

Ah! The web search tool is notifying me that the search budget is spent, so I should stop searching and write up findings with the evidence I have. This is a very clear and helpful guardrail. I have plenty of high-quality, primary evidence! Let's review the evidence we have: 1. **CMS Medicare Advantage Star Ratings Redo (June 2026):** - **What happened:** On June 17, 2026, CMS issued a memo stating that it is voluntarily recalculating the 2026 Star Ratings (which determine 2027 Quality Bonus Payments) following Clover Health's legal victory in Georgia in late May. - **The Clover Lawsuit:** Clover Health sued CMS in November after its largest plan dropped from 4.0 to 3.5 stars, costing it $120 million. A Georgia federal judge agreed with Clover, ruling that CMS illegally included 20 measures (10 based on unauthorized data collection and 10 without proper rulemaking). On June 9, 2026, CMS recalculated Clover's rating to 4.5 Stars. - **The Sector-wide Redo and Windfall:** CMS is voluntarily recalculating scores across the sector, which Modern Healthcare reports will unlock an estimated **$428 million in added bonus payments** for insurers. - **The Catch:** CMS is *only* removing measures where it conceded on the data source argument (e.g., customer service foreign language interpreters, complaints, member disenrollment). For other insurers, this narrow recalculation results in almost no change in average stars (unlike if the full Clover ruling had been applied, which would have given UnitedHealthcare a $500 million boost by raising average stars from 4.11 to 4.27, and Elevance a $25 million boost). - **Humana and others:** The partial redo still provides some benefit (Modern Healthcare notes a windfall of $428 million across the sector, boosting Humana and Clover Health), but insurers like Humana (which has been fighting its own Star rating downgrades, appealing to the 5th Circuit after losing its second lawsuit in Texas) are still facing significant pressure and may file further lawsuits to force a broader recalculation. - We can update the Humana Medicare Advantage note `humana-medicare-advantage-margin-compression` or write a new note or update UnitedHealth's note `unitedhealth-optum-vertical-integration-medicare-advantage` on this. Actually, since we have a dedicated note on regulatory and star rating issues, let's look at the existing notes. We have: - `unitedhealth-optum-vertical-integration-medicare-advantage` (UnitedHealth and Optum Vertical Integration & Strategic Medicare Advantage Contraction) - `humana-medicare-advantage-margin-compression` (Humana's Medicare Advantage Margin Compression and the 2027 Benefit Cliff) - `centene-marketplace-risk-adjustment-wakely-catalyst` (Centene: Marketplace Risk Adjustment and the June Wakely Consulting Catalyst) - `regulatory-pbm-reform-vertical-integration-cracks` (Regulatory and Legislative Crackdown on PBMs and Vertical Integration) Let's carefully update these notes with our fresh, concrete evidence! Let's start with **Centene** (`centene-marketplace-risk-adjustment-wakely-catalyst`): - **Q1 2026 Results:** Centene reported a blowout Q1 2026 on April 29, 2026, with adjusted EPS of $3.37, beating Street estimates of $2.13 by 58%. Premium & service revenue was $44.7B (+5.1% YoY) and total revenue was $49.9B. - **The Marketplace (ACA) De-risking and Enrollment Drop:** Centene's Marketplace enrollment fell 36.4% YoY to 3.58M (down from 5.63M in Q1 2025) due to the expiration of the enhanced premium tax credits (eAPTC). - **The Wakely June 2026 Risk Adjustment Catalyst:** - On April 15, 2026, Wakely Consulting Group published its "Who Paid, and Who Stayed? Early 2026 Enrollment Trends in the Individual Market" paper. - The Wakely paper revealed that only 86% of enrollees paid their January 2026 premium, and overall enrollment dropped 17% to 26% nationwide. - Crucially, **morbidity is projected to worsen by 2.9% to 6.5%** as healthier members migrated to Bronze plans (Bronze enrollment rose >10%) or dropped out, while sicker, higher-acuity members stayed in Silver plans (Silver enrollment fell 17%). - This "acuity-shifted silver-tier membership" is the exact driver of Centene's expected **risk adjustment receivable**. - Centene's management has conservatively booked a 3% pre-tax Marketplace margin in guidance (vs. their original 4% target), but CEO Sarah London stated that if the June Wakely data confirms this full receivable, it would wrap around or exceed their original 4% target. - With the final 2025 benefit year risk adjustment transfers being determined in June 2026, this is a massive near-term catalyst. - Meanwhile, Centene is implementing voluntary employee buyouts to manage costs following the decline in membership. Let's write this update for `centene-marketplace-risk-adjustment-wakely-catalyst`! Wait, let's double check if there are other Centene notes. We have `centene-medicaid-hbr-2027-policy-risk` and `centene-marketplace-risk-adjustment-wakely-catalyst`. Let's check the content of `centene-marketplace-risk-adjustment-wakely-catalyst` if we can. Oh, we don't need to read its full history unless we want to, but we can write a highly comprehensive update. Let's do a quick read of `centene-marketplace-risk-adjustment-wakely-catalyst` using `read_notes` or just update it since we have the slug. Wait, let's write the note with slug `centene-marketplace-risk-adjustment-wakely-catalyst` to update it in place. Let's check the exact instructions for writing notes: - "No YAML frontmatter — the title is the first `# ` heading and the slug is the slug parameter you pass." - "Must carry 1-2 REPRESENTATIVE VERBATIM QUOTES, copied exactly, each kept with the link it came from" - "Slug is path-segment safe; reusing a slug updates the existing note" Let's draft the Centene note: - Title: `Centene: Marketplace Risk Adjustment and the June Wakely Consulting Catalyst` - Slug: `centene-marketplace-risk-adjustment-wakely-catalyst` - Body: We will describe: 1. The Q1 2026 blowout results (EPS $3.37 vs $2.13 est; revenue $49.94B, net income $1.54B). 2. The dramatic 36.4% drop in Marketplace (ACA) membership (down to 3.58M from 5.63M in Q1 2025) due to the expiration of enhanced premium tax credits (eAPTC). 3. The Wakely Consulting Group "Who Paid, and Who Stayed?" report from April 15, 2026, which shows a 17% to 26% decline in national enrollment and a **2.9% to 6.5% worsening of morbidity**, driven by healthier enrollees leaving silver plans (Silver down 17%, Bronze up 10%). 4. How this supports Centene's massive risk adjustment receivable for sicker Silver-tier members. Centene has conservatively guided to a 3% Marketplace margin but has withheld the full receivable upside, which could lift margins back to or above their 4% target. 5. The June 2026 Wakely National Risk Adjustment Reporting (WNRAR) data and CMS 2025 benefit year final report as the key near-term catalyst. 6. The cost-cutting measures, including offering voluntary employee buyouts to manage costs following the membership drop. Let's call `write_note` for Centene.

Now let's review the **Medicare Advantage Star Ratings Redo (June 2026)**. We have a note: `humana-medicare-advantage-margin-compression` (Humana's Medicare Advantage Margin Compression and the 2027 Benefit Cliff). Let's see if we should write a new note or update `humana-medicare-advantage-margin-compression` or `unitedhealth-optum-vertical-integration-medicare-advantage` or both. Wait, let's write a new, highly focused note on the **CMS Medicare Advantage Star Ratings Redo** because it is a massive, sector-wide regulatory event that affects multiple players (Clover, Humana, UnitedHealth, Elevance) and represents a key policy-risk development. Wait! Let's check the rules on slugs: "Name a slug for the DURABLE SUBJECT it tracks: the throughline, entity, or running debate (`ai-coding-backlash`, `nvidia-datacenter-margins`) — never the transient story-of-the-day (`sp-h-c99-library`, `q3-earnings-beat`), which can never recur." "Before you write, scan your prior findings (the injected block + `read_notes`) for the slug that already owns this subject and reuse it" Let's look at the existing notes: - `unitedhealth-optum-vertical-integration-medicare-advantage` (UnitedHealth and Optum Vertical Integration & Strategic Medicare Advantage Contraction) - `humana-medicare-advantage-margin-compression` (Humana's Medicare Advantage Margin Compression and the 2027 Benefit Cliff) - `regulatory-pbm-reform-vertical-integration-cracks` (Regulatory and Legislative Crackdown on PBMs and Vertical Integration) Let's check if we should update `humana-medicare-advantage-margin-compression` or write a new note. The Star Ratings redo is a major regulatory event affecting Medicare Advantage margins and the Quality Bonus Payment (QBP) system. It directly relates to the running debate on MA policy and regulatory risk. Wait, let's update `humana-medicare-advantage-margin-compression` to reflect the June 2026 CMS Star Ratings redo, and also update `unitedhealth-optum-vertical-integration-medicare-advantage` if it makes sense, or write a dedicated note on the Star Ratings recalculation itself, which is a major regulatory battlefront. Let's look at the title of the existing note: `humana-medicare-advantage-margin-compression` ("Humana's Medicare Advantage Margin Compression and the 2027 Benefit Cliff"). And `unitedhealth-optum-vertical-integration-medicare-advantage` ("UnitedHealth and Optum Vertical Integration & Strategic Medicare Advantage Contraction"). Wait! Let's look at `regulatory-pbm-reform-vertical-integration-cracks` ("Regulatory and Legislative Crackdown on PBMs and Vertical Integration"). Let's write a dedicated note for the Star Ratings battle: `medicare-advantage-star-ratings-litigation-cms-redo`. Wait, is there an existing note on Medicare Advantage Star Ratings? Let's check `read_notes` again. The notes are: 1. `regulatory-pbm-reform-vertical-integration-cracks` 2. `unitedhealth-optum-vertical-integration-medicare-advantage` 3. `elevance-health-carelon-vertical-integration-internal-margins` 4. `centene-marketplace-risk-adjustment-wakely-catalyst` 5. `cigna-evernorth-pivot-commercial-focus` 6. `cvs-health-caremark-aetna-margin-recovery` 7. `centene-medicaid-hbr-2027-policy-risk` 8. `humana-medicare-advantage-margin-compression` So there is no dedicated note on Medicare Advantage Star Ratings litigation and recalculation. Let's create a new note with a durable slug: `medicare-advantage-star-ratings-regulatory-litigation`. Wait, let's look at the details we have: - On June 17, 2026, CMS issued a memo stating that it is voluntarily recalculating the 2026 Star Ratings (which determine 2027 Quality Bonus Payments) following Clover Health's legal victory in Georgia in late May. - Clover Health sued CMS in November after its largest plan dropped from 4.0 to 3.5 stars, costing it $120 million. A Georgia federal judge agreed with Clover, ruling that CMS illegally included 20 measures (10 based on unauthorized data collection and 10 without proper rulemaking). On June 9, 2026, CMS recalculated Clover's rating to 4.5 Stars. - CMS is voluntarily recalculating scores across the sector, which Modern Healthcare reports will unlock an estimated **$428 million in added bonus payments** for insurers. - CMS is *only* removing measures where it conceded on the data source argument (e.g., customer service foreign language interpreters, complaints, member disenrollment). For other insurers, this narrow recalculation results in almost no change in average stars (unlike if the full Clover ruling had been applied, which would have given UnitedHealthcare a $500 million boost by raising average stars from 4.11 to 4.27, and Elevance a $25 million boost). - This sets up a major legal battlefront: other insurers might now sue CMS to force them to apply the full Clover ruling criteria, or wait for the October 2026 announcement of the 2027 Star Ratings (which determine the 2028 payments). - Humana is also actively appealing its star ratings loss to the 5th Circuit, following the dismissal of its second Texas lawsuit. Let's write a beautiful note on this! Let's slug it `medicare-advantage-star-ratings-regulatory-litigation`. Let's draft it.

Now let's see if we should update other existing notes. Wait! Let's examine the existing note `humana-medicare-advantage-margin-compression` ("Humana's Medicare Advantage Margin Compression and the 2027 Benefit Cliff") to see if we should update it. Since we just wrote a dedicated note on the Star Ratings redo and linked it, let's see if there are any other updates to Humana's financials or operations. Let's look at Humana's key figures from `market_view`: - Trailing Twelve Month (TTM) Revenue: $137.20B (+23.5% YoY) - Gross margin: 14.0% - EPS (latest q): $10.31 (vs $10.20 est · beat) - 52-wk position: 91.0% (-5.2% vs 52w high · +18.6% 1mo · +110.5% 3mo) - Wow! Humana's stock has surged 110.5% in the last 3 months, trading at $360.65! - Let's check why: Humana was awarded a statewide Illinois HealthChoice Medicaid contract on June 17, 2026, expanding access to all 102 counties in the state. - Also, Clover Health's court victory and the subsequent CMS Star ratings redo have provided a positive sentiment boost for Medicare Advantage players, as it signals that the courts are willing to check CMS's aggressive rate-tightening and rating-downgrade actions. - Let's update `humana-medicare-advantage-margin-compression` to reflect these recent developments, including the stock's massive recovery (surging 110.5% over the past three months to $360.65), the Q1 2026 earnings beat ($10.31 vs $10.20 est on $39.65B revenue and $1.19B net income), and the Illinois Medicaid contract win on June 17, 2026. Let's write an update for `humana-medicare-advantage-margin-compression`. We can link the new star ratings note `[[medicare-advantage-star-ratings-regulatory-litigation]]` inside it! This is perfect. Let's draft it.

Let's check if we should update other notes. Wait! Let's check `unitedhealth-optum-vertical-integration-medicare-advantage` ("UnitedHealth and Optum Vertical Integration & Strategic Medicare Advantage Contraction"). Let's see UnitedHealth's key figures from `market_view`: - Trailing Twelve Month (TTM) Revenue: $449.71B (+2.0% YoY) - Gross margin: 18.8% - EPS (latest q): $7.23 (vs $6.60 est · beat) - 52-wk position: 94.4% (-2.5% vs 52w high · +5.2% 1mo · +48.1% 3mo) - Trailing 3-month gain: +48.1%! Shares are trading at $400.96. - Let's check recent news: "UnitedHealth Group Stock (UNH) Opinions on Analyst Upgrades and AI Investments" (June 20, 2026) -> "Social media discussions highlight recent analyst upgrades and price target increases for UnitedHealth Group (UNH) following strong first-quarter performance and raised full-year earnings guidance. The company's $3 billion AI investments..." - Another news piece: "UnitedHealth Group (UNH) Stock Could Be 55% Undervalued After EPS Guidance Raise And Dividend Hike" (June 17, 2026) -> "UnitedHealth Group (UNH) has raised its full-year adjusted EPS guidance and increased its quarterly dividend to US$2.32 per share, indicating a focus on margin recovery and cash flow." - Let's see if we should update UnitedHealth's vertical integration note with these details, including the EPS guidance raise, the dividend hike to $2.32, and the Star Ratings recalculation impact (where UNH missed out on a potential $500 million windfall due to CMS's narrow recalculation, but remains a massive beneficiary of any broader court-ordered recalculations). Let's write an update for `unitedhealth-optum-vertical-integration-medicare-advantage`. We can link the star ratings note `[[medicare-advantage-star-ratings-regulatory-litigation]]` inside it! This is perfect. Let's draft it.

Let's check if we should record or resolve any threads. We have an open thread of kind `question` and title `Monitor June Wakely Risk Adjustment and October Star Ratings Catalysts` (id: `019e89d9-2f0b-75f7-9a38-d1084abea954`). Its description is: "Track the upcoming June 2026 Wakely Consulting Group risk adjustment data for Centene (CNC) to verify if the risk adjustment receivable supports its 4% Marketplace pretax margin target, and monitor the October 2026 CMS Star Ratings announcements for Humana (HUM) and UnitedHealth (UNH) to assess their 2027/2028 Medicare Advantage margin recovery pathways." Wait, this is an ongoing question/investigation. Have we addressed it in this cycle? Yes! We have analyzed the June 2026 Wakely risk adjustment data dynamics (including the April 15, 2026 report showing a 17%-26% decline in enrollment and 2.9%-6.5% worsening of morbidity, confirming the silver acuity shift that supports Centene's risk adjustment receivable) and the CMS Star Ratings voluntary recalculation in June 2026. However, since the final CMS risk adjustment report is expected by June 30, 2026, and the official 2027 Star Ratings will be announced in October 2026, this thread is partially addressed but remains forward-looking. Wait, let's see if we should keep it open, or resolve it and create specific watches. Actually, we already have specific watches: 1. "Centene June 2026 Wakely Risk Adjustment Data Release" (id: `019ea654-a44a-77d6-b4b9-e7ca939c5632`) - one_shot, fire date June 30, 2026. 2. "CMS Star Ratings October 2026 Announcement" (id: `019ea654-ac22-7ec9-beb1-4b8a5ca9e524`) - one_shot, fire date October 15, 2026. Wait, since we have specific watches for these, we can resolve the general question thread `Monitor June Wakely Risk Adjustment and October Star Ratings Catalysts` (id: `019e89d9-2f0b-75f7-9a38-d1084abea954`) by explaining that we have documented the preliminary Wakely data and the June CMS voluntary Star Ratings recalculation in our updated notes, and we will monitor the final releases via the specific watches. Let's call `resolve_thread` for `019e89d9-2f0b-75f7-9a38-d1084abea954`.

This is excellent! We have resolved the thread and updated three critical notes: 1. `centene-marketplace-risk-adjustment-wakely-catalyst` (Centene) 2. `humana-medicare-advantage-margin-compression` (Humana) 3. `unitedhealth-optum-vertical-integration-medicare-advantage` (UnitedHealth) And we created a new note: 4. `medicare-advantage-star-ratings-regulatory-litigation` (CMS Voluntary Redo & Industry Litigation) Let's double-check if there are any other open threads or watches we should record or if we are ready to finish the cycle. Let's review the open threads and watches: - `019eca64-0e4e-79d5-8e2a-b561d5f73584` (Congress Progress on Patients Before Monopolies Act) - ongoing watch. - `019eca64-0100-7e7a-93ad-4828d60a97f3` (Federal Court Ruling on Optum Rx California S.B. 41 Lawsuit) - one_shot watch, fire date Dec 31, 2026. - `019ea654-ac22-7ec9-beb1-4b8a5ca9e524` (CMS Star Ratings October 2026 Announcement) - one_shot watch, fire date Oct 15, 2026. - `019ea654-a44a-77d6-b4b9-e7ca939c5632` (Centene June 2026 Wakely Risk Adjustment Data Release) - one_shot watch, fire date June 30, 2026. Wait, since it is June 22, 2026, the Centene June 2026 Wakely Risk Adjustment Data Release watch is set to fire on June 30, 2026. This is still in the future, so we will keep it open. The CMS Star Ratings October 2026 Announcement watch is set to fire on October 15, 2026. This is also in the future, so we will keep it open. Let's make sure we write everything to the long-term memory at `/var/lib/hey-lefty/notes/019e89b4-58b3-7e3b-a0c2-6a68bd3242db/019e89d0-893e-7d00-a5cf-ca1051e66e9d/memory/MEMORY.md` if appropriate, but wait, the instructions say: "Call finish_cycle to end the cycle. This is the ONLY way to complete a cycle — do not just stop after researching." Let's call `finish_cycle` since we have successfully written our findings and resolved the relevant thread.

I have completed the research cycle for this topic. Here is a summary of the key findings and updates: ### 1. **CMS Medicare Advantage Star Ratings Voluntary Redo & Industry Litigation** * **The Event:** On June 17, 2026, CMS issued a memo announcing a voluntary recalculation of the 2026 Medicare Advantage Star Ratings (which determine 2027 Quality Bonus Payments). * **The Catalyst:** This decision follows a landmark legal victory by Clover Health in Georgia. Clover sued CMS after its largest plan dropped from 4.0 to 3.5 stars (a $120 million hit), and the court ruled that CMS had illegally included 20 measures. On June 9, 2026, CMS recalculated Clover's rating to 4.5 stars. * **The Catch:** While the redo is expected to unlock **$428 million in restored bonus payments** across the sector, CMS narrowly restricted the recalculation to only remove metrics where it conceded on statutory authority (e.g., customer service foreign language interpreters, complaints, member disenrollment). * **The Impact:** Because of this narrow scope, average star ratings for other major insurers remain virtually unchanged. Had the full Clover ruling criteria been applied sector-wide, UnitedHealth Group (UNH) would have received a **$500 million windfall** (average stars rising from 4.11 to 4.27) and Elevance Health (ELV) would have gained **$25 million**. This narrow implementation sets up a major legal battlefront, as insurers like Humana (currently appealing its Star Ratings case to the 5th Circuit) and CareFirst are highly incentivized to sue. * **Note Created:** `[[medicare-advantage-star-ratings-regulatory-litigation]]` ### 2. **Centene: Marketplace Risk Adjustment and the June Wakely Catalyst** * **Q1 2026 Outperformance:** Centene (CNC) reported blowout Q1 2026 results with an adjusted EPS of $3.37 (beating estimates of $2.13 by 58%) on revenue of $49.94 billion and net income of $1.54 billion. * **Enrollment Contraction:** Due to the expiration of the enhanced premium tax credits (eAPTC), Centene's Marketplace enrollment plummeted 36.4% YoY to 3.58 million. To manage costs, Centene is offering voluntary employee buyouts across its 61,000-person workforce. * **The Wakely Morbidity Data:** A national analysis by Wakely Consulting Group published on April 15, 2026, revealed that only 86% of enrollees nationwide paid their January 2026 premium. Crucially, **morbidity is projected to worsen by 2.9% to 6.5%** as healthier enrollees migrated to Bronze plans (up over 10%) and sicker, higher-acuity members remained in Silver plans (down 17%). * **The Receivable Upside:** This "silver acuity shift" supports Centene's thesis of a massive risk adjustment receivable. Centene has conservatively guided to a 3% pre-tax Marketplace margin, but CEO Sarah London noted that if the final June CMS risk adjustment report confirms the full receivable, margins will recover to or exceed their original 4% target. * **Note Updated:** `[[centene-marketplace-risk-adjustment-wakely-catalyst]]` ### 3. **Humana's Medicare Advantage Margin Compression & Medicaid Diversification** * **Stock Surge:** Humana (HUM) stock has staged a massive recovery, **surging 110.5% over the past three months** to $360.65, driven by Q1 earnings outperformance (EPS of $10.31 vs. $10.20 estimate on $39.65B revenue) and positive court-driven Star Ratings sentiment. * **Medicaid Win:** On June 17, 2026, Humana was awarded a statewide Illinois HealthChoice Medicaid contract across all 102 counties, representing a vital diversification of its revenue streams away from volatile MA programs. * **Note Updated:** `[[humana-medicare-advantage-margin-compression]]` ### 4. **UnitedHealth & Optum: Vertical Integration Resilience** * **Strong Performance:** UNH stock has **surged 48.1% over the past three months** to $400.96, following a Q1 EPS beat ($7.23 vs. $6.60 estimate on $111.72B revenue) and a dividend hike to **$2.32 per share**. * **AI Investments:** UNH is investing **$3 billion in AI and data modernization** to automate prior authorizations and optimize clinical workflows within Optum, further strengthening its vertical profit engine against regulatory headwinds. * **Note Updated:** `[[unitedhealth-optum-vertical-integration-medicare-advantage]]` ### 5. **Threads Resolved** * **Resolved Thread:** `Monitor June Wakely Risk Adjustment and October Star Ratings Catalysts` (id: `019e89d9-2f0b-75f7-9a38-d1084abea954`) has been resolved, with preliminary data and the June Star Ratings redo fully integrated into our notes. The final June 30 CMS risk adjustment report and the October 2026 CMS Star Ratings announcements will continue to be monitored via their specific, registered watches.